- Home
- ALTG vs ALLO Comparison
ALTG vs ALLO Comparison
Compare ALTG & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- ALLO
- Stock Information
- Founded
- ALTG 1984
- ALLO 2017
- Country
- ALTG United States
- ALLO United States
- Employees
- ALTG N/A
- ALLO N/A
- Industry
- ALTG Industrial Machinery/Components
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALTG Industrials
- ALLO Health Care
- Exchange
- ALTG Nasdaq
- ALLO Nasdaq
- Market Cap
- ALTG 247.6M
- ALLO 252.9M
- IPO Year
- ALTG N/A
- ALLO 2018
- Fundamental
- Price
- ALTG $7.15
- ALLO $1.13
- Analyst Decision
- ALTG Hold
- ALLO Strong Buy
- Analyst Count
- ALTG 3
- ALLO 10
- Target Price
- ALTG $11.67
- ALLO $8.88
- AVG Volume (30 Days)
- ALTG 254.4K
- ALLO 3.0M
- Earning Date
- ALTG 11-11-2025
- ALLO 11-06-2025
- Dividend Yield
- ALTG 3.04%
- ALLO N/A
- EPS Growth
- ALTG N/A
- ALLO N/A
- EPS
- ALTG N/A
- ALLO N/A
- Revenue
- ALTG $1,851,100,000.00
- ALLO N/A
- Revenue This Year
- ALTG $1.30
- ALLO N/A
- Revenue Next Year
- ALTG $3.26
- ALLO $100.00
- P/E Ratio
- ALTG N/A
- ALLO N/A
- Revenue Growth
- ALTG N/A
- ALLO N/A
- 52 Week Low
- ALTG $3.54
- ALLO $0.86
- 52 Week High
- ALTG $8.99
- ALLO $3.78
- Technical
- Relative Strength Index (RSI)
- ALTG 38.28
- ALLO 47.86
- Support Level
- ALTG $7.27
- ALLO $1.09
- Resistance Level
- ALTG $7.69
- ALLO $1.21
- Average True Range (ATR)
- ALTG 0.34
- ALLO 0.07
- MACD
- ALTG -0.13
- ALLO 0.01
- Stochastic Oscillator
- ALTG 1.29
- ALLO 33.33
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.